CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-24 | Rubin Eric H Director | Grant or award | +5 | 5 | ||
| 2026-04-24 | Chapman Rowan E Director | Grant or award | +114 | 5,866 | ||
| 2026-04-24 | Chapman Rowan E Director | Grant or award | +222 | 6,088 | ||
| 2026-04-24 | Bertagnolli Monica Director | Grant or award | +83 | 5,374 | ||
| 2026-04-24 | Marcus Gail Boxer Director | Grant or award | +108 | 5,961 | ||
| 2026-04-24 | Marcus Gail Boxer Director | Grant or award | +222 | 6,183 | ||
| 2026-04-24 | Baynes Roy D. Director | Grant or award | +83 | 18,512 | ||
| 2026-04-24 | Williams Brinkley Ruth Director | Grant or award | +86 | 5,475 | ||
| 2026-04-24 | ROSENMAN HERM Director | Grant or award | +117 | 20,558 | ||
| 2026-04-24 | ROSENMAN HERM Director | Grant or award | +222 | 20,780 | ||
| 2026-04-24 | BOTHA ROELOF Director | Grant or award | +132 | 2,672 | ||
| 2026-04-24 | BOTHA ROELOF Director | Grant or award | +222 | 2,894 | ||
| 2026-04-17 | Sheena Jonathan Director | Sale 10b5-1 | −750 | $199.66 | $150K | 20,282 |
| 2026-04-17 | Sheena Jonathan Director | Sale 10b5-1 | −750 | $199.59 | $150K | 20,282 |
| 2026-04-06 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Option exercise | +58,292 | $9.59 | $559K | 2,410,772 |
| 2026-04-06 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Shares withheld for taxes | −27,610 | $204.87 | $5.7M | 2,383,162 |
| 2026-04-06 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Option exercise · Stock Option (right to buy) | −58,292 | 0 | ||
| 2026-04-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,048 | $201.32 | $211K | 149,834 |
| 2026-04-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,000 | $202.36 | $202K | 148,834 |
| 2026-04-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −952 | $203.31 | $194K | 147,882 |
Page 21 of 55 · 1,093 trades